TASC II Section F on Revascularization: Commentary from an Interventionist's Point of View

Norgren L Hiatt WR Dormandy JA . Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). Section F: Revascularization. Eur J Vasc Endovasc Surg. 2007; 33(Suppl 1): S54–S64.

Dormandy JA Rutherford RB . Management of peripheral arterial disease (PAD). TASC Working Group. TransAtlantic Inter-Society Consensus (TASC). J Vasc Surg. 2000; 31: S1–S296.

Tetteroo E van der Graaf Y Bosch JL . Randomised comparison of primary stent placement versus primary angioplasty followed by selective stent placement in patients with iliac-artery occlusive disease. Dutch Iliac Stent Trial Study Group. Lancet. 1998; 351: 1153–1159.

Klein WM van der Graaf Y Seegers J . Dutch iliac stent trial: Long-term results in patients randomized for primary or selective stent placement. Radiology. 2006; 238: 734–744.

Adam DJ Beard JD Cleveland T . Bypass surgery versus angioplasty in severe ischaemia of the leg (BASIL): Multicentre, randomised controlled trial. Lancet. 2005; 366: 1925–1934.

Ponec D Jaff MR Swischuk J . The nitinol SMART stent vs. Wallstent for suboptimal iliac artery angioplasty: CRISP-US trial results. J Vasc Interv Radiol. 2004; 15: 911–918.

Bosch JL Hunink MG . Meta-analysis of the results of percutaneous transluminal angioplasty and stent placement for aortoiliac occlusive disease. Radiology. 1997; 204: 87–96.

Cejna M Turnher S Illiasch H . PTA versus Palmaz stent in femoropopliteal artery obstructions: A multicenter prospective randomized study. J Vasc Interv Radiol. 2001; 12: 23–31.

Vroegineweij D Vos LD Tielbeek AV . Balloon angioplasty combined with primary stenting versus balloon angioplasty alone in femoropopliteal obstructions: A comparative randomized study. Cardiovasc Intervent Radiol. 1997; 20: 420–425.

Grimm J Müller-Hülsbeck S Jahnke T . Randomized study to compare PTA with Palmaz stent placement for femoropopliteal lesions. J Vasc Interv Radiol. 2001; 12: 935–942.

Zdanowski Z Albrechtsson U Lundin A . Percutaneous transluminal angioplasty with or without stenting for femoropopliteal occlusions? A randomized controlled study. Int Angiol. 1999; 18: 251–255.

Becquemin JP Favre JP Marzelle J . Systematic vs. selective stent placement after superficial femoral artery balloon angioplasty: A multicenter prospective randomised study. J Vasc Surg. 2003; 37: 487–494.

Duda SH Pusich B Richter G . Sirolimus-eluting stents for the treatment of obstructive superficial femoral artery disease: Six-months results. Circulation. 2002; 106: 1505–1509.

Schillinger M Sabeti S Loewe C . Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery. N Engl J Med. 2006; 354: 1879–1888.

Krankenberg H for the FAST Investigators. Femoral artery stenting trial–12-month final analysis. Presented at Transcatheter Cardiovascular Therapies; October 22–27, 2006; Washington, DC, USA.

Duda SH Bosiers M Lammer J . Drug-eluting and bare nitinol stents for the treatment of atherosclerotic lesions in the superficial femoral artery: Long-term results from the SIROCCO trial. J Endovasc Ther. 2006; 13: 701–710.

Schillinger M Mlekusch W Haumer M . Angioplasty and elective stenting of de novo versus recurrent femoropopliteal lesions: 1-year follow-up. J Endovasc Ther. 2003; 10: 288–297.

Capek P McLean GK Berkowitz HD . Femoropopliteal angioplasty. Factors influencing long-term success. Circulation. 1991; 83(2 Suppl)I70–I80.